Treace Medical Named First Medical Device Partner and Official Foot and Ankle Solution Partner of the PPA Tour
April 24, 2024 07:00 ET
|
Treace Medical Concepts, Inc.
DALLAS and PONTE VEDRA, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- The Professional Pickleball Association (PPA) Tour and Treace Medical Concepts, Inc. (NasdaqGS: TMCI), a medical technology company...
Treace to Present at Bank of America Health Care Conference
April 17, 2024 07:00 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Announces First Annual National Bunion Day
April 16, 2024 07:00 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace to Report First Quarter 2024 Financial Results
April 09, 2024 07:00 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., April 09, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Celebrates 100,000 Lapiplasty® 3D Bunion Correction® Patient Milestone
March 25, 2024 07:00 ET
|
Treace Medical Concepts, Inc.
Treace Further Expands Focus on Bunion Deformity Education by Sponsoring First-Ever National Bunion Day in the U.S. on April 16, 2024 Launches New “Future You” Patient Education and Brand...
Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance
February 27, 2024 16:05 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace to Report Fourth Quarter and Full-Year 2023 Financial Results
February 07, 2024 16:05 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
February 02, 2024 12:00 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference
February 01, 2024 07:00 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue
January 08, 2024 07:00 ET
|
Treace Medical Concepts, Inc.
PONTE VEDRA, Fla., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...